1.Liao Y, Zuo M, Xu T, et al. Estimated glucose disposal rate andrisk of incident hyperuricemia: insights fromCHARLS. Sci Rep. 2025 Nov 11;15(1):39439. (I F=3.9, 中科院三区, 第一作者)
2. Zuo M, Liao Y, He P, et al. p53 andPD-1/PD-L1 expression contribute to disease progression andare correlated to immune infiltrates in urothelial carcinoma.Sci Rep 15, 36072 (2025). (IF=3.9, 中科院三区, 共同第一作者)
3. Liao Y, Zuo M, Zhu Y, et al. Nomogram forpredicting postoperative clinical remission of hypertension in patients with adrenal tumors. Discov Oncol. 2025 Mar 17;16(1):341. (IF=2.9, 中科院四区,第一作者)
4.Cui W, Liao YJ, Su P, et al. Synovial sarcoma of female urethra: a case report andreview of the literature. Diagn Pathol. 2023 Jul 3;18(1):78. (IF=2.6,中科院三区,共同第一作者)
5. Zuo M, Chen H, Liao Y, et al. Sulforaphane andbladder cancer: a potential novel antitumorcompound. Front Pharmacol. 2023 Sep 15;14:1254236. (IF=4.9,中科院二区,第二作者)
6.廖远键,姚菁菁,左明顺,等.转移性嗜铬细胞瘤和副神经节瘤遗传学研究进展[J].实用医学杂志,2023,39(23):3137-3142. (北图核心,第一作者)
7.范龙梅,唐佳佳,黄天渝,廖远键,等.共济失调毛细血管扩张突变基因在膀胱癌治疗中的研究现状[J].肿瘤,2024,44(10):1044-1050. (科技核心,第四作者)